AI-generated summary
The authors retrospectively reviewed 146 patients treated with a 532-nm KTP laser for facial superficial vascular lesions at a single dermatology clinic. Favorable outcomes (clearance or marked improvement) were reported in 93.5% for spider angioma, 66.1% for telangiectasia, and 26.7% for erythema, with minimal adverse effects in 3.4% of patients. The retrospective, single-center design is a limitation the abstract itself implies.
- Participants
- 146
- Who or what was studied
- 146 patients with facial superficial cutaneous vascular lesions (telangiectasia, spider angioma, erythema) treated at a single outpatient dermatology clinic
- Wavelengths
- 532 nm
- Limits stated in the abstract
- Data were collected retrospectively from a single center, and the abstract provides no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.